Prostate Cancer Survival Articles

Articles

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy.

Prostate cancer (PCa) testing involves a complex individually based decision-making process. It should consider competing risks from other comorbidities when estimating a survival benefit from the early detection of clinically significant (cs)PCa.

Published May 1, 2019
Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.

Aspirin use probably protects against some malignancies but its effects on lethal prostate cancer (PC) are unclear.
To investigate the association between regular aspirin use and lethal PC.
Participants were aged 40-75 yr at baseline in 1986 and have been followed with biennial questionnaires.
Published April 25, 2019
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy.

Prostate-specific-membrane-antigen/positron emission tomography (PSMA-PET) detects with high accuracy disease-recurrence, leading to changes in the management of biochemically-recurrent (BCR) prostate cancer (PCa).
Published February 28, 2022